Literature DB >> 15727849

Design, synthesis, antibacterial and QSAR studies of benzimidazole and imidazole chloroaryloxyalkyl derivatives.

A Khalafi-Nezhad1, M N Soltani Rad, H Mohabatkar, Z Asrari, B Hemmateenejad.   

Abstract

In view of obtaining some potential antibacterial compounds, we have described synthesis of some chloroaryloxyalkyl imidazole and benzimidazole derivatives. The relevant step in the synthetic sequence was the initial condensation of 4-chloro or 2,4-dichlorophenol with 1, n-dibromoalkanes (n=2, 4, 5) to provide compounds 3a-f in sufficient yields. The subsequent condensation of 3a-f with some imidazole derivatives and benzimidazole afforded products 4a-l and 5a-e in good yields. Some of compounds 4a-l as well as 5a-e were tested in vitro against Salmonella typhi O-901 and Staphylococcus aureus A 15091. Compounds 4a and 4c showed considerable bactericidal activities against tested bacteria. Compound 4b showed significant activity against S. aureus A 15091 but was inactive against S. typhi O-901. Other compounds showed intermediate activities against S. aureus A 15091 but most of them were inactive against S. typhi O-901. Semiempirical AM1 calculations showed that negative electrostatic potentials around oxygen of the phenoxy and nitrogen of the imidazole moieties have direct effect on the antibacterial activity towards S. aureus A 15091. In QSAR analysis, different electronic, topologic, functional groups and physicochemical descriptors were calculated for each molecule and a three parametric equation was found between the logMIC and HOMO energy, hydration energy and number of primary carbon atoms of the molecules.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15727849     DOI: 10.1016/j.bmc.2005.01.014

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  16 in total

1.  Synthesis, characterization, DNA binding and cleavage studies of mixed-ligand Cu(II) complexes of 2,6-bis(benzimidazol-2-yl)pyridine.

Authors:  M Sunita; M Padmaja; B Anupama; C Gyana Kumari
Journal:  J Fluoresc       Date:  2012-05       Impact factor: 2.217

2.  4-[3-(2H-Benzotriazol-2-yl)prop-oxy]-3-methoxy-benzaldehyde.

Authors:  Lei Jin; Cheng-He Zhou
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-05-08

3.  3-Meth-oxy-4-[3-(2-methyl-4-nitro-1H-imidazol-1-yl)prop-oxy]benzaldehyde.

Authors:  Lei Jin; Guang-Zhou Wang; Cheng-He Zhou
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-08-15

4.  Synthesis and quantitative structure activity relationship (QSAR) of arylidene (benzimidazol-1-yl)acetohydrazones as potential antibacterial agents.

Authors:  Yeldez El-Kilany; Nariman M Nahas; Mariam A Al-Ghamdi; Mohamed E I Badawy; El Sayed H El Ashry
Journal:  World J Microbiol Biotechnol       Date:  2014-10-11       Impact factor: 3.312

5.  Comparative biological study between quinazolinyl-triazinyl semicarbazide and thiosemicarbazide hybrid derivatives.

Authors:  Janki J Patel; Rahul P Modh; Manjoorahmed Asamdi; Kishor H Chikhalia
Journal:  Mol Divers       Date:  2020-06-28       Impact factor: 2.943

6.  Synthesis and characterization of the ligand based on benzimidazole and its copper complex: DNA binding and antioxidant activity.

Authors:  Huilu Wu; Fan Kou; Fei Jia; Bin Liu; Jingkun Yuan; Ying Bai
Journal:  Bioinorg Chem Appl       Date:  2011-11-21       Impact factor: 7.778

7.  Ethyl 1-(2-hy-droxy-eth-yl)-2-propyl-1H-benzimidazole-5-carboxyl-ate.

Authors:  Nurasyikin Hamzah; Nurziana Ngah; Shafida Abd Hamid; Aisyah Saad Abdul Rahim
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-09-30

8.  Synthesis and biological activities of some benzimidazolone derivatives.

Authors:  B K Karale; S S Rindhe; M A Rode
Journal:  Indian J Pharm Sci       Date:  2015 Mar-Apr       Impact factor: 0.975

9.  Synthesis and antifungal activity of benzimidazole, benzotriazole and aminothiazole derivatives.

Authors:  S Khabnadideh; Z Rezaei; K Pakshir; K Zomorodian; N Ghafari
Journal:  Res Pharm Sci       Date:  2012-04

10.  N'-[(E)-1-(4-Bromo-phen-yl)ethyl-idene]-2-(2-methyl-4-nitro-1H-imidazol-1-yl)acetohydrazide.

Authors:  Hoong-Kun Fun; Ching Kheng Quah; Priya V Frank; N Damodara; Balakrishna Kalluraya
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.